Your browser doesn't support javascript.
loading
Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma.
Kuzuya, Teiji; Kawabe, Naoto; Hashimoto, Senju; Miyahara, Ryoji; Sawaki, Akira; Nakano, Takuji; Nakaoka, Kazunori; Tanaka, Hiroyuki; Miyachi, Yohei; Mii, Arisa; Kamejima, Sayaka; Takahara, Takeshi; Kato, Yutaro; Sugioka, Atsushi; Hirooka, Yoshiki.
Afiliação
  • Kuzuya T; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Kawabe N; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Hashimoto S; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Miyahara R; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Sawaki A; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Nakano T; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Nakaoka K; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Tanaka H; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Miyachi Y; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Mii A; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Kamejima S; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
  • Takahara T; Department of Surgery, Fujita Health University, Toyoake, Japan.
  • Kato Y; Department of Surgery, Fujita Health University, Toyoake, Japan.
  • Sugioka A; Department of Surgery, Fujita Health University, Toyoake, Japan.
  • Hirooka Y; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
Oncology ; 100(1): 12-21, 2022.
Article em En | MEDLINE | ID: mdl-34731863

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa-Fetoproteínas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa-Fetoproteínas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão